Annual EBITDA
-$25.51 M
-$4.38 M-20.70%
December 31, 2023
Summary
- As of February 26, 2025, CGTX annual EBITDA is -$25.51 million, with the most recent change of -$4.38 million (-20.70%) on December 31, 2023.
- During the last 3 years, CGTX annual EBITDA has fallen by -$19.52 million (-325.86%).
- CGTX annual EBITDA is now -582.61% below its all-time high of -$3.74 million, reached on December 31, 2019.
Performance
CGTX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$9.86 M
-$2.90 M-41.58%
September 30, 2024
Summary
- As of February 26, 2025, CGTX quarterly EBITDA is -$9.86 million, with the most recent change of -$2.90 million (-41.58%) on September 30, 2024.
- Over the past year, CGTX quarterly EBITDA has dropped by -$3.18 million (-47.62%).
- CGTX quarterly EBITDA is now -1359.77% below its all-time high of $783.00 thousand, reached on March 31, 2021.
Performance
CGTX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$33.98 M
-$3.18 M-10.33%
September 30, 2024
Summary
- As of February 26, 2025, CGTX TTM EBITDA is -$33.98 million, with the most recent change of -$3.18 million (-10.33%) on September 30, 2024.
- Over the past year, CGTX TTM EBITDA has dropped by -$11.43 million (-50.65%).
- CGTX TTM EBITDA is now -1441.04% below its all-time high of -$2.21 million, reached on March 31, 2020.
Performance
CGTX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
CGTX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -20.7% | -47.6% | -50.6% |
| 3 y3 years | -325.9% | -47.6% | -50.6% |
| 5 y5 years | -582.6% | -47.6% | -50.6% |
CGTX EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -137.7% | at low | -170.4% | at low | -216.7% | at low |
| 5 y | 5-year | -582.6% | at low | -1359.8% | at low | -1441.0% | at low |
| alltime | all time | -582.6% | at low | -1359.8% | at low | -1441.0% | at low |
Cognition Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$9.86 M(+41.6%) | -$33.98 M(+10.3%) |
| Jun 2024 | - | -$6.97 M(-23.3%) | -$30.80 M(+8.1%) |
| Mar 2024 | - | -$9.08 M(+12.6%) | -$28.49 M(+11.7%) |
| Dec 2023 | -$25.51 M(+20.7%) | -$8.07 M(+20.7%) | -$25.51 M(+13.1%) |
| Sep 2023 | - | -$6.68 M(+43.4%) | -$22.55 M(+0.5%) |
| Jun 2023 | - | -$4.66 M(-23.6%) | -$22.44 M(-4.9%) |
| Mar 2023 | - | -$6.10 M(+19.4%) | -$23.59 M(+11.6%) |
| Dec 2022 | -$21.13 M | -$5.11 M(-22.1%) | -$21.13 M(-9.4%) |
| Sep 2022 | - | -$6.56 M(+12.9%) | -$23.34 M(+17.5%) |
| Jun 2022 | - | -$5.81 M(+59.3%) | -$19.86 M(+31.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$3.65 M(-50.1%) | -$15.16 M(+41.3%) |
| Dec 2021 | -$10.73 M(+79.1%) | -$7.32 M(+137.0%) | -$10.73 M(+126.9%) |
| Sep 2021 | - | -$3.09 M(+178.4%) | -$4.73 M(+62.9%) |
| Jun 2021 | - | -$1.11 M(-241.6%) | -$2.90 M(-3.3%) |
| Mar 2021 | - | $783.00 K(-159.5%) | -$3.00 M(-49.9%) |
| Dec 2020 | -$5.99 M(+60.3%) | -$1.31 M(+4.3%) | -$5.99 M(+28.1%) |
| Sep 2020 | - | -$1.26 M(+4.3%) | -$4.67 M(+36.9%) |
| Jun 2020 | - | -$1.21 M(-45.2%) | -$3.41 M(+54.8%) |
| Mar 2020 | - | -$2.21 M | -$2.21 M |
| Dec 2019 | -$3.74 M | - | - |
FAQ
- What is Cognition Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for Cognition Therapeutics?
- What is Cognition Therapeutics annual EBITDA year-on-year change?
- What is Cognition Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Cognition Therapeutics?
- What is Cognition Therapeutics quarterly EBITDA year-on-year change?
- What is Cognition Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Cognition Therapeutics?
- What is Cognition Therapeutics TTM EBITDA year-on-year change?
What is Cognition Therapeutics annual EBITDA?
The current annual EBITDA of CGTX is -$25.51 M
What is the all time high annual EBITDA for Cognition Therapeutics?
Cognition Therapeutics all-time high annual EBITDA is -$3.74 M
What is Cognition Therapeutics annual EBITDA year-on-year change?
Over the past year, CGTX annual EBITDA has changed by -$4.38 M (-20.70%)
What is Cognition Therapeutics quarterly EBITDA?
The current quarterly EBITDA of CGTX is -$9.86 M
What is the all time high quarterly EBITDA for Cognition Therapeutics?
Cognition Therapeutics all-time high quarterly EBITDA is $783.00 K
What is Cognition Therapeutics quarterly EBITDA year-on-year change?
Over the past year, CGTX quarterly EBITDA has changed by -$3.18 M (-47.62%)
What is Cognition Therapeutics TTM EBITDA?
The current TTM EBITDA of CGTX is -$33.98 M
What is the all time high TTM EBITDA for Cognition Therapeutics?
Cognition Therapeutics all-time high TTM EBITDA is -$2.21 M
What is Cognition Therapeutics TTM EBITDA year-on-year change?
Over the past year, CGTX TTM EBITDA has changed by -$11.43 M (-50.65%)